Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model

Erstveröffentlichung
2015Authors
Hasan, Md. Nabiul
Queudeville, Manon
Trentin, Luca
Eckhoff, Sarah Mirjam
Bronzini, Ilaria
Wissenschaftlicher Artikel
Published in
Oncotarget ; 6 (2015), 3. - S. 1382-1395. - ISSN 1949-2553
Institutions
UKU. Klinik für Kinder- und JugendmedizinUKU. Institut für Pathologie
DFG Project THU
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
Project uulm
IGradU / International Graduate School der Universität Ulm
Subject headings
[Free subject headings]: Acute lymphoblastic leukemia | pediatric | xenograft model | mTOR hyperactivation | preclinical targeting | t-cell leukemia | testing program | mammalian target | kinase inhibitor | poor-prognosis | b-progenitor | rapamycin | expression | crlf2 | pathway[DDC subject group]: DDC 610 / Medicine & health